Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LMO4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DBI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM223 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNORD3D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TEX14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RYBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101928615 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD17B8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB27A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNHG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERGIC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC16A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INTS5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPRC5D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MLEC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHLDA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on